Crescent Pharma recalls Ramipril 5mg capsules due to manufacturing error
Crescent Pharma Limited is recalling a batch of Ramipril 5 mg Capsules due to a potential manufacturing error.
Asset / Drug
Drug and asset intelligence for Crescent with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
ACE Inhibitor
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.